Government Context
Documents
Following
Sign in
Documents
Documents by topic
Documents by agency
Following
Sign in
Details
Dockets
›
Requests that the FDA declare that the drug product, Solifenacin Oral Solution, 1 mg/mL is suitable for submission in an Abbreviated New Drug Application
›
Response Letter
Response Letter
Nonrulemaking
Other
FDA-2021-P-0567-0006
Pharmaceutical Policy
🔔 Subscribe
Document
Details
The document's own metadata, straight from regulations.gov.
Posted
Jun 10, 2026
Agency
Food and Drug Administration (FDA)
